Beyond the Patent - HealthTech Hub Masterclass
Description
The Challenge of Translation.
In the world of medical research, the path from a breakthrough discovery to a clinical reality is rarely a straight line. While a patent is a significant milestone, it is only one piece of the puzzle. To truly drive impact, researchers and entrepreneurs must understand how intellectual property (IP) determines market access, partnership opportunities, and the long-term viability of their innovations.
What You Will Learn: This masterclass, hosted at the Children’s Medical Research Institute (CMRI), is designed to give clinicians, researchers, and founders the "due diligence" toolkit needed to work effectively with tech transfer offices and commercial partners.
By attending this session, you will be able to:
Understand the IP Spectrum: Identify different types of Intellectual Property and their specific relevance to clinical innovation.
Navigate the Patent Lifecycle: Describe the stages of the patent process from application to grant, including critical timelines and filing strategies.
Clarify Ownership: Distinguish between inventorship and ownership, and understand how these impact your legal rights and obligations.
Assess Patentability: Learn to evaluate research discoveries based on novelty, inventive step, and industrial applicability.
Secure Freedom to Operate (FTO): Understand how FTO influences your ability to commercialise a product without infringing on existing rights.
Build Your Network: Identify the key stakeholders to engage with, including IP lawyers and research offices.
-----------
Don't miss this opportunity to gain valuable insights from industry experts and network with fellow health tech innovators.
Lineup
Gavin Recchia (Principal Patent Attorney, DCC)
With over 24 years of experience in the biotech and pharmaceutical sectors, Gavin specialises in protecting complex IP in molecular biology, genetics, and medical devices.
Laura Wimburger (Science Analyst, Proto Axiom)
A PhD in chemistry who helps founders transition from a research perspective to a compelling commercial narrative that attracts investors.
Robert Gorkin (Co-founder of Eudaemon Technologies, Co-Director of THRI) WSU)
Seasoned research entrepreneur, Co-director and Professor at Translational Health Research Institute and Co-founder of Eudaemon Technologies, Robert's work spans health and medtech, advanced manufacturing, biotechnology, and ML/AI with a focus on innovation leadership, strategic management, and effective governance.
Noam Pilpel (Venture Lead, University of Sydney)
A biotech professional with 20 years of experience bridging the gap between science and the commercial arena, having successfully raised funding from international VCs.
Reg Leones (Head of Legal, CMRI)
An experienced IP lawyer and patent attorney with a focus on life sciences and medical device litigation.
FAQs
- What is the Cicada HealthTech Hub?
Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses are to help bridge the gap between research and commercialisation.
Find out more about the Cicada HealthTech Hub
The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.
Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity
RSVP
This event has passedRSVP
This event has passed
